Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronan Foley

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
The Lancet. Oncology|January 3, 2016
Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: a randomised, controlled, open-label, phase 3, multicentre trialIrwin Walker, Tony Panzarella, Stephen Couban, et al.
The Lancet. Haematology|January 21, 2020
Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trialIrwin Walker, Tony Panzarella, Stephen Couban, et al.
Molecular Therapy. Methods & Clinical Development|February 23, 2023
Persistent hematopoietic polyclonality after lentivirus-mediated gene therapy for Fabry diseaseAmr H Saleh, Michael Rothe, Dwayne L Barber, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 26, 2006
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. Design of Clinical Trials Working Group reportPaul J Martin, Daniel Weisdorf, Donna Przepiorka, et al.
Cell Chemical Biology|June 27, 2017
Sam68 Allows Selective Targeting of Human Cancer Stem CellsYannick D Benoit, Ryan R Mitchell, Ruth M Risueño, et al.
Cell Reports. Medicine|July 11, 2023
Leukemic progenitor compartment serves as a prognostic measure of cancer stemness in patients with acute myeloid leukemiaAllison L Boyd, Justin Lu, Cameron G Hollands, et al.
Cell Reports. Medicine|April 6, 2024
Identification of cells of leukemic stem cell origin with non-canonical regenerative propertiesCameron G Hollands, Allison L Boyd, Xueli Zhao, et al.
Journal for Immunotherapy of Cancer|February 9, 2025
Real-world outcomes with tisagenlecleucel in aggressive B-cell lymphoma: subgroup analyses from the CIBMTR registryDaniel J Landsburg, Matthew J Frigault, Michael Heim, et al.
Nature Cell Biology|October 17, 2017
Acute myeloid leukaemia disrupts endogenous myelo-erythropoiesis by compromising the adipocyte bone marrow nicheAllison L Boyd, Jennifer C Reid, Kyle R Salci, et al.
Cancer Immunology Research|September 9, 2016
Tn-MUC1 DC Vaccination of Rhesus Macaques and a Phase I/II Trial in Patients with Nonmetastatic Castrate-Resistant Prostate CancerElizabeth Scheid, Pierre Major, Alain Bergeron, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
The Lancet. Oncology|January 3, 2016
Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: a randomised, controlled, open-label, phase 3, multicentre trialIrwin Walker, Tony Panzarella, Stephen Couban, et al.
The Lancet. Haematology|January 21, 2020
Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trialIrwin Walker, Tony Panzarella, Stephen Couban, et al.
Molecular Therapy. Methods & Clinical Development|February 23, 2023
Persistent hematopoietic polyclonality after lentivirus-mediated gene therapy for Fabry diseaseAmr H Saleh, Michael Rothe, Dwayne L Barber, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 26, 2006
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. Design of Clinical Trials Working Group reportPaul J Martin, Daniel Weisdorf, Donna Przepiorka, et al.
Cell Chemical Biology|June 27, 2017
Sam68 Allows Selective Targeting of Human Cancer Stem CellsYannick D Benoit, Ryan R Mitchell, Ruth M Risueño, et al.
Cell Reports. Medicine|July 11, 2023
Leukemic progenitor compartment serves as a prognostic measure of cancer stemness in patients with acute myeloid leukemiaAllison L Boyd, Justin Lu, Cameron G Hollands, et al.
Cell Reports. Medicine|April 6, 2024
Identification of cells of leukemic stem cell origin with non-canonical regenerative propertiesCameron G Hollands, Allison L Boyd, Xueli Zhao, et al.
Journal for Immunotherapy of Cancer|February 9, 2025
Real-world outcomes with tisagenlecleucel in aggressive B-cell lymphoma: subgroup analyses from the CIBMTR registryDaniel J Landsburg, Matthew J Frigault, Michael Heim, et al.
Nature Cell Biology|October 17, 2017
Acute myeloid leukaemia disrupts endogenous myelo-erythropoiesis by compromising the adipocyte bone marrow nicheAllison L Boyd, Jennifer C Reid, Kyle R Salci, et al.
Cancer Immunology Research|September 9, 2016
Tn-MUC1 DC Vaccination of Rhesus Macaques and a Phase I/II Trial in Patients with Nonmetastatic Castrate-Resistant Prostate CancerElizabeth Scheid, Pierre Major, Alain Bergeron, et al.
Pageof 9